SEMA3A and neoplasm: Similar to previous reports, we found that SEMA3A was either up- or down-regulated in different cancer types, but we only found SEMA3A associated with poor prognosis in a number of cancer types (SARC, LUAD, HNSC, LGG, KIRC, and KIRP), where the expression of SEMA3A in tumours were all up-regulated.